GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40938)

  • GC79614 structure
    GC796145α-Dihydrocortisol
    CAS: 516-41-6
    Purity: >98.00%

    5α-Dihydrocortisol (5α-DHF), a metabolite of Hydrocortisone (Cortisol), is a steroid hormone.

  • GC79615 structure
    GC7961520α-Dihydrocortisol
    CAS: 1719-79-5
    Purity: >96.50%

    20α-Dihydrocortisol (20α-DHF) is a metabolite of Hydrocortisone (Cortisol) [1] .

  • GC79616 structure
    GC79616Acetaminophen glucuronide potassium
    Purity: >99.50%

    Acetaminophen glucuronide potassium (APAP-glu potassium) is the inactive glucuronide metabolite of Acetaminophen.

  • GC79617 structure
    GC79617Clethodim sulfoxide
    CAS: 111031-14-2
    Purity: >98.00%

    Clethodim sulfoxide is the aerobic metabolite of clethodim, a cyclohexanedione oxime herbicide [1] .

  • GC79618 structure
    GC79618Prucalopride N-oxide
    CAS: 1900715-98-1
    Purity: >98.00%

    Prucalopride N-oxide is a metabolite of Prucalopride with motility-enhancing effects [1] .

  • GC79619 structure
    GC79619Fipronil sulfide
    CAS: 120067-83-6
    Purity: >98.00%

    Fipronil sulfide is a toxic, persistent metabolite of Fipronil.

  • GC79620 structure
    GC79620Dapagliflozin keto impurity
    CAS: 2169998-23-4
    Purity: >98.00%

    Dapagliflozin keto impurity (Oxo-dapagliflozin) is an oxo metabolite and related impurity of Dapagliflozin.

  • GC79621 structure
    GC796215α,6α-Epoxysitosterol
    CAS: 53034-66-5
    Purity: >99.50%

    5α,6α-Epoxysitosterol is a minor β-sitosterol oxidation product and 5,6-epoxy thermo-oxidation product of sitosterol [1] [2] .

  • GC79622 structure
    GC79622Ginsenoside C-Y
    CAS: 83480-65-3
    Purity: >98.00%

    Ginsenoside C-Y (Ginsenoside Y) is a metabolite of Ginsenoside Rb2.

  • GC79623 structure
    GC79623Ichangin
    CAS: 10171-61-6
    Purity: >98.00%

    Ichangin is a metabolite of ponderosa lemon Citrus pyriformis.

  • GC79624 structure
    GC7962441-O-Demethylrapamycin
    CAS: 142382-16-9
    Purity: >98.00%

    41-O-Demethylrapamycin is a metabolite of Rapamycin produced by Bacillus megaterium [1] .

  • GC79625 structure
    GC79625Febuxostat 67M-1
    CAS: 887945-96-2
    Purity: >95.00%

    Febuxostat 67M-1 is an active metabolite of Febuxostat.

  • GC79626 structure
    GC79626H111-H7
    CAS: 220965-54-8
    Purity: >98.00%

    H111-H7 is a WW domain containing E3 ubiquitin 27 protein ligase 2 ( WWP2 ) inhibitor with a K D of 717 nM.

  • GC79627 structure
    GC79627H36-E4
    CAS: 688310-17-0
    Purity: >98.50%

    H36-E4 is a WW domain containing E3 ubiquitin 27 protein ligase 2 ( WWP2 ) inhibitor with a K D of 6.25 μM.

  • GC79628 structure
    GC79628XMU-MP-10
    CAS: 2251132-02-0
    Purity: >98.00%

    XMU-MP-10 is a selective NEDD4 inhibitor with a K D of 43.92 nM.

  • GC79629 structure
    GC79629ZER1 binder-2
    CAS: 3132618-63-1
    Purity: >98.00%

    ZER1 binder-2 is a ZER1 E3 ubiquitin ligase binder with an EC 50 value of 51.04 nM.

  • GC79630 structure
    GC79630MRC37
    Purity: >98.50%

    MRC37 is a high-affinity TRIM21 ligand with a K d of 0.4 µM.

  • GC79631 structure
    GC79631JWP24 acetate
    Purity: >98.00%

    JWP24 acetate is the first cell membrane-permeable peptide inhibitor of MAGE-A4, with an IC 50 of 200 nM against human MAGE-A4.

  • GC79632 structure
    GC79632Pyrrolidone carboxylic acid
    CAS: 115621-24-4
    Purity: >98.00%

    Pyrrolidone carboxylic acid (PCA) is one of the main components (accounting for approximately 12%) of natural moisturizing factors (NMF) in the mammalian epidermal stratum corneum, and it is produced by the degradation of filaggrin.

  • GC79633 structure
    GC79633trans-Caffeic aldehyde
    CAS: 141632-15-7
    Purity: >98.00%

    Trans-Caffeic aldehyde is a type of phenylpropanoid compound, which was discovered in the secondary metabolites of the actinomycete Acrocarpospora punica.

  • GC79634 structure
    GC79634N-Methylnorsalsolinol
    CAS: 37491-98-8
    Purity: >99.50%

    N-Methylnorsalsolinol is an endogenous MPTP -like compound.

  • GC79635 structure
    GC796353-Methylundecane
    CAS: 1002-43-3
    Purity: >98.00%

    3-Methylundecane is a volatile compound that can be isolated from the Panax ginseng essential oil [1] .

  • GC79636 structure
    GC79636(RS)-Pantoic acid sodium monohydrate
    Purity: >98.00%

    (RS) -Pantoic acid sodium monohydrate is an intermediate in the phosphopantothenate biosynthesis pathway for the de novo synthesis of R-pantothenate (vitamin B5) from valine in plants and microorganisms.

  • GC79637 structure
    GC79637L-Indole-3-lactic acid
    CAS: 7417-65-4
    Purity: >98.00%

    L-Indole-3-lactic acid is an L (-)-tryptophan metabolite found in strains of Bifidobacterium, Lactobacillus plantarum and Lactobacillus paraplantarum, and also an indole-based antioxidant.